Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease

od Hager, Klaus, Baseman, Alan S, Nye, Jeffrey S, Brashear, H Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M
Wydane 2014

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-contro...

od Hager, Klaus, Baseman, Alan S., Nye, Jeffrey S., Brashear, H. Robert, Han, John, Sano, Mary, Davis, Bonnie, Richards, Henry M.
Wydane w Alzheimers Res Ther (2016)

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheim...

od Delnomdedieu, Marielle, Duvvuri, Sridhar, Li, David Jianjun, Atassi, Nazem, Lu, Ming, Brashear, H. Robert, Liu, Enchi, Ness, Seth, Kupiec, James W.
Wydane w Alzheimers Res Ther (2016)

Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis

od Arrighi, H Michael, Barakos, Jerome, Barkhof, Frederik, Tampieri, Donatella, Jack, Clifford, Melançon, Denis, Morris, Kristen, Ketter, Nzeera, Liu, Enchi, Brashear, H Robert
Wydane w J Neurol Neurosurg Psychiatry (2016)

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized con...

od Prins, Niels D, van der Flier, Wiesje A, Knol, Dirk L, Fox, Nick C, Brashear, H Robert, Nye, Jeffrey S, Barkhof, Frederik, Scheltens, Philip
Wydane w Alzheimers Res Ther (2014)

Suicidal ideation and behavior assessment in dementia studies: An Internet survey

od Chappell, Phillip, Dubrava, Sarah, Stewart, Michelle, Hartley, Dean M., Alphs, Larry, Brashear, H. Robert, Conwell, Yeates, Miller, David, Schindler, Rachel J., Siemers, Eric R., Yaffe, Kristine
Wydane w Alzheimers Dement (N Y) (2016)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab

od Samtani, Mahesh N., Xu, Steven X., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Wydane w Alzheimers Dement (N Y) (2015)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials

od Xu, Steven X., Samtani, Mahesh N., Russu, Alberto, Adedokun, Omoniyi J., Lu, Ming, Ito, Kaori, Corrigan, Brian, Raje, Sangeeta, Brashear, H. Robert, Styren, Scot, Hu, Chuanpu
Wydane w Alzheimers Dement (N Y) (2015)

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-contro...

od Novak, Gerald, Streffer, Johannes Rolf, Timmers, Maarten, Henley, David, Brashear, H. Robert, Bogert, Jennifer, Russu, Alberto, Janssens, Luc, Tesseur, Ina, Tritsmans, Luc, Van Nueten, Luc, Engelborghs, Sebastiaan
Wydane w Alzheimers Res Ther (2020)

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies

od Ivanoiu, Adrian, Pariente, Jérémie, Booth, Kevin, Lobello, Kasia, Luscan, Gerald, Hua, Lisa, Lucas, Prisca, Styren, Scot, Yang, Lingfeng, Li, David, Black, Ronald S., Brashear, H. Robert, McRae, Thomas
Wydane w Alzheimers Res Ther (2016)

The pathway to secondary prevention of Alzheimer's disease

od McDade, Eric, Bednar, Martin M., Brashear, H. Robert, Miller, David S., Maruff, Paul, Randolph, Christopher, Ismail, Zahinoor, Carrillo, Maria C., Weber, Christopher J., Bain, Lisa J., Hake, Ann Marie
Wydane w Alzheimers Dement (N Y) (2020)

Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia

od Alphs, Larry, Brashear, H. Robert, Chappell, Phillip, Conwell, Yeates, Dubrava, Sarah, Khin, Ni A., Kozauer, Nicholas, Hartley, Dean M., Miller, David S., Schindler, Rachel J., Siemers, Eric R., Stewart, Michelle, Yaffe, Kristine
Wydane w Alzheimers Dement (N Y) (2016)

Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

od Sperling, Reisa A., Jack, Clifford R., Black, Sandra E., Frosch, Matthew P., Greenberg, Steven M., Hyman, Bradley T., Scheltens, Philip, Carrillo, Maria C., Thies, William, Bednar, Martin M., Black, Ronald S., Brashear, H. Robert, Grundman, Michael, Siemers, Eric R., Feldman, Howard H., Schindler, Rachel J.
Wydane 2011

Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial

od Sperling, Reisa, Henley, David, Aisen, Paul S., Raman, Rema, Donohue, Michael C., Ernstrom, Karin, Rafii, Michael S., Streffer, Johannes, Shi, Yingqi, Karcher, Keith, Raghavan, Nandini, Tymofyeyev, Yevgen, Bogert, Jennifer, Brashear, H. Robert, Novak, Gerald, Thipphawong, John, Saad, Ziad S., Kolb, Hartmuth, Rofael, Hany, Sanga, Panna, Romano, Gary
Wydane w JAMA Neurol (2021)

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

od Vandenberghe, Rik, Rinne, Juha O., Boada, Mercè, Katayama, Sadao, Scheltens, Philip, Vellas, Bruno, Tuchman, Michael, Gass, Achim, Fiebach, Jochen B., Hill, Derek, Lobello, Kasia, Li, David, McRae, Tom, Lucas, Prisca, Evans, Iona, Booth, Kevin, Luscan, Gerald, Wyman, Bradley T., Hua, Lisa, Yang, Lingfeng, Brashear, H. Robert, Black, Ronald S.
Wydane w Alzheimers Res Ther (2016)

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer’s Disease

od Salloway, Stephen, Sperling, Reisa, Fox, Nick C., Blennow, Kaj, Klunk, William, Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Ferris, Steven, Reichert, Marcel, Ketter, Nzeera, Nejadnik, Bijan, Guenzler, Volkmar, Miloslavsky, Maja, Wang, Daniel, Lu, Yuan, Lull, Julia, Tudor, Iulia Cristina, Liu, Enchi, Grundman, Michael, Yuen, Eric, Black, Ronald, Brashear, H. Robert
Wydane 2014

Amyloid-β (11)C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

od Liu, Enchi, Schmidt, Mark E., Margolin, Richard, Sperling, Reisa, Koeppe, Robert, Mason, Neale S., Klunk, William E., Mathis, Chester A., Salloway, Stephen, Fox, Nick C., Hill, Derek L., Les, Andrea S., Collins, Peter, Gregg, Keith M., Di, Jianing, Lu, Yuan, Tudor, I. Cristina, Wyman, Bradley T., Booth, Kevin, Broome, Stephanie, Yuen, Eric, Grundman, Michael, Brashear, H. Robert
Wydane w Neurology (2015)